ShangPharma Announces Strategic Corporate Restructuring of … – Yahoo Finance
SHANGHAI, March 24, 2017 /PRNewswire/ — ShangPharma, a leading life science partnering organization providing high-quality and cost-effective drug development and discovery services, technology, and investment for the pharmaceutical and biotechnology industry, announced today the intent for a strategic corporate restructuring. ShangPharma will be consolidating the Contract Research Organizations (CRO) and Contract Manufacturing Organizations (CMO) under…